HUE033071T2 - Vakcinakészítmények - Google Patents
VakcinakészítményekInfo
- Publication number
- HUE033071T2 HUE033071T2 HUE11728059A HUE11728059A HUE033071T2 HU E033071 T2 HUE033071 T2 HU E033071T2 HU E11728059 A HUE11728059 A HU E11728059A HU E11728059 A HUE11728059 A HU E11728059A HU E033071 T2 HUE033071 T2 HU E033071T2
- Authority
- HU
- Hungary
- Prior art keywords
- vaccine formulations
- vaccine
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/19—Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
- A61M5/2448—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic comprising means for injection of two or more media, e.g. by mixing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35180410P | 2010-06-04 | 2010-06-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE033071T2 true HUE033071T2 (hu) | 2017-11-28 |
Family
ID=44627561
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE11728059A HUE033071T2 (hu) | 2010-06-04 | 2011-05-25 | Vakcinakészítmények |
HUE16201544A HUE048398T2 (hu) | 2010-06-04 | 2011-05-25 | Vakcinakészítmények |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE16201544A HUE048398T2 (hu) | 2010-06-04 | 2011-05-25 | Vakcinakészítmények |
Country Status (18)
Country | Link |
---|---|
US (1) | US9095567B2 (hu) |
EP (3) | EP3626263A1 (hu) |
JP (2) | JP5959161B2 (hu) |
KR (1) | KR101609032B1 (hu) |
CN (2) | CN107080838A (hu) |
AU (1) | AU2011262346B2 (hu) |
BR (1) | BR112012030950B1 (hu) |
CA (1) | CA2799747C (hu) |
DK (2) | DK3170508T3 (hu) |
ES (2) | ES2764674T3 (hu) |
HU (2) | HUE033071T2 (hu) |
IL (1) | IL223206A (hu) |
MX (1) | MX2012013664A (hu) |
PL (2) | PL3170508T3 (hu) |
PT (2) | PT3170508T (hu) |
RU (1) | RU2607024C2 (hu) |
SI (2) | SI3170508T1 (hu) |
WO (1) | WO2011151760A2 (hu) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI3170508T1 (sl) * | 2010-06-04 | 2020-01-31 | Wyeth Llc | Formulacije cepiva |
WO2013063258A1 (en) | 2011-10-25 | 2013-05-02 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
KR20200053644A (ko) * | 2012-05-15 | 2020-05-18 | 세럼 인스티튜트 오브 인디아 프라이비트 리미티드 | 보강제 제형 및 방법 |
KR102057217B1 (ko) | 2012-06-20 | 2020-01-22 | 에스케이바이오사이언스 주식회사 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
KR20140075196A (ko) * | 2012-12-11 | 2014-06-19 | 에스케이케미칼주식회사 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
US9707155B2 (en) | 2013-04-24 | 2017-07-18 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9839579B2 (en) | 2013-04-24 | 2017-12-12 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9603775B2 (en) | 2013-04-24 | 2017-03-28 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9700486B2 (en) | 2013-04-24 | 2017-07-11 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9707153B2 (en) * | 2013-04-24 | 2017-07-18 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9713572B2 (en) | 2013-04-24 | 2017-07-25 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9707154B2 (en) | 2013-04-24 | 2017-07-18 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9700485B2 (en) | 2013-04-24 | 2017-07-11 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9849066B2 (en) | 2013-04-24 | 2017-12-26 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9717649B2 (en) | 2013-04-24 | 2017-08-01 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9717648B2 (en) | 2013-04-24 | 2017-08-01 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
WO2014186754A2 (en) * | 2013-05-16 | 2014-11-20 | Board Of Regents The University Of Texas System | Dry solid aluminum adjuvant-containing vaccines and related methods thereof |
US11160855B2 (en) * | 2014-01-21 | 2021-11-02 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
CN103893751B (zh) * | 2014-03-26 | 2016-04-20 | 天津康希诺生物技术有限公司 | 一种肺炎球菌多糖蛋白缀合疫苗及其制备方法 |
JP6882193B2 (ja) * | 2015-04-28 | 2021-06-02 | バイオロジカル イー リミテッド | 微生物莢膜多糖類からタンパク質および他の不純物を分離するための方法 |
EP3307307A4 (en) | 2015-06-09 | 2019-05-01 | The Board of Regents of the University of Oklahoma | COMPOSITIONS AND TREATMENTS FOR HAEMOPHILUS INFLUENZAE |
EP3344276B1 (en) | 2015-09-03 | 2020-04-22 | The Board of Regents of the University of Oklahoma | Peptide inhibitors of clostridium difficile tcdb toxin |
CN105233296B (zh) * | 2015-11-24 | 2018-08-17 | 江苏省农业科学院 | 用于鸭病毒性肝炎活疫苗的耐热冻干保护剂及其制备方法和应用 |
EA039370B1 (ru) | 2016-04-14 | 2022-01-19 | Мериал, Инк. | Иммуногенная многодозовая композиция, содержащая антимикробный полиамидный консервант |
BR112019004303A2 (pt) * | 2016-09-06 | 2019-05-28 | Lg Chemical Ltd | composição de conjugados multivalentes de polissacarídeo capsular pneumocócico-proteína portadora e uso da mesma |
CN106822884B (zh) * | 2016-12-28 | 2021-04-30 | 北京民海生物科技有限公司 | 一种多价肺炎球菌荚膜多糖结合疫苗的制备方法 |
US11844829B2 (en) | 2016-12-28 | 2023-12-19 | Zalvac Ab | Microparticles from Streptococcus pneumoniae as vaccine antigens |
US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
WO2018144438A1 (en) * | 2017-01-31 | 2018-08-09 | Merck Sharp & Dohme Corp. | Methods for production of capsular polysaccharide protein conjugates from streptococcus pneumoniae serotype 19f |
CN110225764A (zh) | 2017-01-31 | 2019-09-10 | 默沙东公司 | 制备多糖-蛋白缀合物的方法 |
AU2018225099A1 (en) | 2017-02-24 | 2019-07-25 | Merck Sharp & Dohme Llc | Enhancing immunogenicity of Streptococcus pneumoniae polysaccharide-protein conjugates |
WO2018169303A1 (ko) * | 2017-03-15 | 2018-09-20 | 주식회사 엘지화학 | 다가 폐렴구균 백신 조성물 |
US10729763B2 (en) | 2017-06-10 | 2020-08-04 | Inventprise, Llc | Mixtures of polysaccharide-protein pegylated compounds |
BR112019026192B1 (pt) | 2017-06-10 | 2022-05-10 | Inventprise, Llc | Vacinas de conjugado multivalente com polissacarídeos de conjugado bivalente ou multivalente que fornecem imunogenicidade e avidez melhoradas |
US11395849B2 (en) | 2017-09-07 | 2022-07-26 | Merck Sharp & Dohme Llc | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
BR112020004502A8 (pt) | 2017-09-07 | 2022-11-01 | Merck Sharp & Dohme | Polissacarídeos pneumocócicos e uso dos mesmos em conjugados imunogênicos polissacarídeo-proteína carreadora |
US11491216B2 (en) | 2017-09-07 | 2022-11-08 | Merck Sharp & Dohme Llc | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
SG11202005255PA (en) | 2017-12-06 | 2020-07-29 | Merck Sharp & Dohme | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
CA3083953A1 (en) | 2017-12-11 | 2019-06-20 | Board Of Regents, The University Of Texas System | Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration |
US11123417B2 (en) | 2018-02-05 | 2021-09-21 | Sanofi Pasteur Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
EP3556728A1 (en) * | 2018-04-16 | 2019-10-23 | Croda Denmark A/S | Organically modified mineral micro-particles, methods of preparing the same and uses thereof |
CA3096358A1 (en) | 2018-04-18 | 2019-10-24 | Sk Bioscience Co., Ltd. | Streptococcus pneumoniae capsular polysaccharide and immunogenic conjugate thereof |
JP7397000B2 (ja) | 2018-04-30 | 2023-12-12 | メルク・シャープ・アンド・ドーム・エルエルシー | 凍結乾燥変異ジフテリア毒素のジメチルスルホキシド中均一溶液を提供する方法 |
EA202190318A1 (ru) * | 2018-07-21 | 2021-04-29 | Байолоджикал И Лимитед | Составы вакцин, содержащие систему консервантов |
JP7275277B2 (ja) | 2018-12-19 | 2023-05-17 | メルク・シャープ・アンド・ドーム・エルエルシー | ストレプトコッカス・ニューモニエ多糖-タンパク質コンジュゲートを含む組成物およびその使用方法 |
CN116121106A (zh) * | 2021-07-08 | 2023-05-16 | 成都生物制品研究所有限责任公司 | 肺炎链球菌无动物源冻干保护剂 |
WO2023218322A1 (en) | 2022-05-11 | 2023-11-16 | Pfizer Inc. | Process for producing of vaccine formulations with preservatives |
Family Cites Families (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4902506A (en) | 1983-07-05 | 1990-02-20 | The University Of Rochester | Immunogenic conjugates |
US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
SE8405493D0 (sv) | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
US5078996A (en) | 1985-08-16 | 1992-01-07 | Immunex Corporation | Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor |
US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
FR2630115B1 (fr) | 1988-04-14 | 1994-10-28 | Merieux Inst | Procede de stabilisation des solutions d'albumine humaine et solution obtenue |
US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
HU212924B (en) | 1989-05-25 | 1996-12-30 | Chiron Corp | Adjuvant formulation comprising a submicron oil droplet emulsion |
EP0467173B1 (en) | 1990-07-19 | 1995-11-08 | Nardino Righi | Disposable safety syringe |
IL101715A (en) | 1991-05-02 | 2005-06-19 | Amgen Inc | Recombinant dna-derived cholera toxin subunit analogs |
US5769047A (en) | 1991-12-23 | 1998-06-23 | Zoche; Michael | Engine with oil separator |
IT1253009B (it) | 1991-12-31 | 1995-07-10 | Sclavo Ricerca S R L | Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini |
SG49909A1 (en) | 1992-06-25 | 1998-06-15 | Smithkline Beecham Biolog | Vaccine composition containing adjuvants |
ATE280235T1 (de) | 1993-03-05 | 2004-11-15 | Wyeth Corp | Plasmid zur herstellung von crm-protein und diphtherie-toxin |
GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
JP3696267B2 (ja) | 1994-02-28 | 2005-09-14 | 天野エンザイム株式会社 | 生理活性蛋白質の安定化方法 |
US5571515A (en) | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
RU2087156C1 (ru) * | 1995-06-22 | 1997-08-20 | Леонид Николаевич Падюков | Вакцина против пневмококковой инфекции |
US6355255B1 (en) | 1998-12-07 | 2002-03-12 | Regents Of The University Of Minnesota | Streptococcal C5a peptidase vaccine |
US5846547A (en) | 1996-01-22 | 1998-12-08 | Regents Of The University Of Minnesota | Streptococcal C5a peptidase vaccine |
RU2098109C1 (ru) | 1996-09-26 | 1997-12-10 | Александр Григорьевич Чучалин | Противоаллергическое, противовоспалительное средство, способ его получения, лечебное и косметическое средства с его использованием |
JP4078406B2 (ja) | 1997-01-22 | 2008-04-23 | 有限会社コーキ・エンジニアリング | 注射器のシリンダの製造方法 |
US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
US6224880B1 (en) | 1997-09-24 | 2001-05-01 | Merck & Co., Inc. | Immunization against Streptococcus pneumoniae using conjugated and unconjugated pneumoccocal polysaccharide vaccines |
CA2264970A1 (en) | 1998-03-10 | 1999-09-10 | American Cyanamid Company | Antigenic conjugates of conserved lipolysaccharides of gram negative bacteria |
PT1117435E (pt) | 1998-09-30 | 2008-02-21 | Us Gov Univ Health Sciences | Holotoxina da cólera mutante como adjuvante |
SI1162999T1 (sl) * | 1999-03-19 | 2007-04-30 | Glaxosmithkline Biolog Sa | Vakcina proti Streptococcus pneumoniae |
GB9909077D0 (en) * | 1999-04-20 | 1999-06-16 | Smithkline Beecham Biolog | Novel compositions |
EP1233784B1 (en) | 1999-12-02 | 2008-07-09 | Novartis Vaccines and Diagnostics, Inc. | Compositions and methods for stabilizing biological molecules upon lyophilization |
DE10012370A1 (de) | 2000-03-14 | 2001-09-27 | Chiron Behring Gmbh & Co | Adjuvans für Vakzinen |
PT1296713E (pt) | 2000-06-08 | 2004-02-27 | Intercell Biomediz Forschungs | Oligodesoxinucleotidos imunoestimuladores |
GB0108364D0 (en) | 2001-04-03 | 2001-05-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
NZ523319A (en) * | 2000-06-29 | 2006-01-27 | Glaxosmithkline Biolog Sa | Vaccine compositions comprising Pw, TT, DT and H. influenzae type B (Hib) with a lower dose of Hib (5 mcg) compared with the standard does (10 mcg) |
KR100385711B1 (ko) | 2000-07-05 | 2003-05-27 | 녹십자백신 주식회사 | 디프테리아, 파상풍 톡소이드와 백일해균 및b형간염표면항원을 포함한 4가 혼합백신 및 그 제조방법 |
AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
CA2449663A1 (en) | 2001-06-07 | 2002-12-12 | Wyeth Holdings Corporation | Mutant forms of cholera holotoxin as an adjuvant |
AU2002322380B2 (en) | 2001-06-07 | 2006-11-02 | Government Of The United States Of America As Represented By The Uniformed Services University Of The Health Sciences | Mutant forms of cholera holotoxin as an adjuvant |
MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
DK1441589T3 (da) | 2001-11-08 | 2012-08-06 | Abbott Biotherapeutics Corp | Stabil, flydende, farmaceutisk sammensætning af IgG-antistoffer |
US20070148729A1 (en) | 2003-01-15 | 2007-06-28 | Farley John E | Methods for increasing neisseria protein expression and compositions thereof |
EP2172213B1 (en) | 2003-01-30 | 2013-04-03 | Novartis AG | Injectable vaccines against multiple meningococcal serogroups |
CN1771053B (zh) | 2003-02-10 | 2012-10-03 | 伊兰药品公司 | 免疫球蛋白制剂及其制备方法 |
CA2519511A1 (en) | 2003-03-17 | 2004-09-30 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
WO2004094596A2 (en) | 2003-04-16 | 2004-11-04 | Wyeth Holdings Corporation | Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
EP1635822A4 (en) | 2003-06-25 | 2009-06-24 | Elan Pharm Inc | METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS |
UA67144A (en) | 2003-07-29 | 2004-06-15 | Inst Exprm & Clinical Veterina | Method for production of inactivated vaccine against salmonellosis and escherichiosis of animals |
DE10348550A1 (de) | 2003-10-20 | 2005-06-16 | Hexal Biotech Forschungsgmbh | Stabile wässrige G-CSF-haltige Zusammensetzungen |
RU37462U1 (ru) | 2004-01-16 | 2004-04-27 | Бычкова Ольга Владимировна | Пробирка |
KR20070107079A (ko) | 2005-01-28 | 2007-11-06 | 와이어쓰 | 안정화된 액체 폴리펩타이드 제형 |
US7955605B2 (en) * | 2005-04-08 | 2011-06-07 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
US20070184072A1 (en) | 2005-04-08 | 2007-08-09 | Wyeth | Multivalent pneumococcal polysaccharide-protein conjugate composition |
EP2425851A1 (en) * | 2005-04-08 | 2012-03-07 | Wyeth LLC | Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition |
JP5135220B2 (ja) * | 2005-09-01 | 2013-02-06 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー | 血清群c髄膜炎菌を含む複数ワクチン接種 |
KR100659373B1 (ko) * | 2006-02-09 | 2006-12-19 | 서울옵토디바이스주식회사 | 패터닝된 발광다이오드용 기판 및 그것을 채택하는 발광다이오드 |
AU2007227504B2 (en) * | 2006-03-17 | 2013-10-31 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Methods for preparing complex multivalent immunogenic conjugates |
TW200806315A (en) * | 2006-04-26 | 2008-02-01 | Wyeth Corp | Novel formulations which stabilize and inhibit precipitation of immunogenic compositions |
WO2007127668A2 (en) | 2006-04-26 | 2007-11-08 | Wyeth | Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations |
US8808707B1 (en) * | 2006-05-08 | 2014-08-19 | Wyeth Llc | Pneumococcal dosing regimen |
CN105944095B (zh) | 2008-03-05 | 2021-04-02 | 赛诺菲巴斯德有限公司 | 一种使含佐剂的疫苗组合物稳定的方法 |
DE102009056871A1 (de) * | 2009-12-03 | 2011-06-22 | Novartis AG, 4056 | Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben |
PL2569267T5 (pl) * | 2010-05-12 | 2017-10-31 | Novartis Ag | Ulepszone sposoby otrzymywania skwalenu |
SI3170508T1 (sl) * | 2010-06-04 | 2020-01-31 | Wyeth Llc | Formulacije cepiva |
WO2012078482A1 (en) * | 2010-12-10 | 2012-06-14 | Merck Sharp & Dohme Corp. | Novel formulations which mitigate agitation-induced aggregation of immunogenic compositions |
PL3150222T3 (pl) * | 2010-12-22 | 2020-05-18 | Wyeth Llc | Stabilne immunogenne kompozycje antygenów staphylococcus aureus |
SG10201605401WA (en) * | 2011-04-01 | 2016-08-30 | Wyeth Llc | Antibody-drug conjugates |
KR20200053644A (ko) * | 2012-05-15 | 2020-05-18 | 세럼 인스티튜트 오브 인디아 프라이비트 리미티드 | 보강제 제형 및 방법 |
-
2011
- 2011-05-25 SI SI201131824T patent/SI3170508T1/sl unknown
- 2011-05-25 BR BR112012030950A patent/BR112012030950B1/pt active IP Right Grant
- 2011-05-25 CN CN201710133332.0A patent/CN107080838A/zh active Pending
- 2011-05-25 DK DK16201544.0T patent/DK3170508T3/da active
- 2011-05-25 HU HUE11728059A patent/HUE033071T2/hu unknown
- 2011-05-25 CN CN2011800276637A patent/CN102933229A/zh active Pending
- 2011-05-25 CA CA2799747A patent/CA2799747C/en active Active
- 2011-05-25 WO PCT/IB2011/052275 patent/WO2011151760A2/en active Application Filing
- 2011-05-25 PL PL16201544T patent/PL3170508T3/pl unknown
- 2011-05-25 PT PT162015440T patent/PT3170508T/pt unknown
- 2011-05-25 DK DK11728059.4T patent/DK2575870T3/en active
- 2011-05-25 MX MX2012013664A patent/MX2012013664A/es active IP Right Grant
- 2011-05-25 PT PT117280594T patent/PT2575870T/pt unknown
- 2011-05-25 ES ES16201544T patent/ES2764674T3/es active Active
- 2011-05-25 EP EP19201327.4A patent/EP3626263A1/en active Pending
- 2011-05-25 SI SI201131063A patent/SI2575870T1/sl unknown
- 2011-05-25 EP EP16201544.0A patent/EP3170508B1/en active Active
- 2011-05-25 KR KR1020137000115A patent/KR101609032B1/ko active IP Right Grant
- 2011-05-25 HU HUE16201544A patent/HUE048398T2/hu unknown
- 2011-05-25 RU RU2012151376A patent/RU2607024C2/ru not_active Application Discontinuation
- 2011-05-25 US US13/701,707 patent/US9095567B2/en active Active
- 2011-05-25 AU AU2011262346A patent/AU2011262346B2/en active Active
- 2011-05-25 PL PL11728059T patent/PL2575870T3/pl unknown
- 2011-05-25 EP EP11728059.4A patent/EP2575870B1/en active Active
- 2011-05-25 ES ES11728059.4T patent/ES2614807T3/es active Active
- 2011-06-02 JP JP2011124221A patent/JP5959161B2/ja active Active
-
2012
- 2012-11-22 IL IL223206A patent/IL223206A/en active IP Right Grant
-
2015
- 2015-03-24 JP JP2015061740A patent/JP2015143252A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL223206A0 (en) | Vaccine formulations | |
GB201005005D0 (en) | New vaccine | |
GB201015132D0 (en) | Vaccine composition | |
EP2755680A4 (en) | PARTICULATE VACCINE FORMULATIONS | |
ZA201301950B (en) | Bvdv vaccine | |
GB201014965D0 (en) | Vaccine | |
ZA201300194B (en) | Formulations | |
GB201110193D0 (en) | Formulations | |
GB201013513D0 (en) | Formulations | |
GB201013006D0 (en) | Vaccine | |
GB201006324D0 (en) | Vaccine | |
ZA201302154B (en) | Vaccine | |
ZA201300196B (en) | Formulations | |
GB201012283D0 (en) | Vaccine | |
GB201007588D0 (en) | Vaccine | |
GB201007589D0 (en) | Vaccine | |
GB201018648D0 (en) | Formulations | |
GB201018649D0 (en) | Formulations | |
GB201018645D0 (en) | Formulations | |
GB201018647D0 (en) | Formulations | |
GB201012589D0 (en) | Formulations | |
GB201010494D0 (en) | Formulations | |
GB201008470D0 (en) | Formulations | |
GB201008358D0 (en) | Formulations | |
GB201007959D0 (en) | Formulations |